Suppr超能文献

相似文献

1
Cystic fibrosis and Crohn's disease: successful treatment and long term remission with infliximab.
World J Gastroenterol. 2010 Apr 21;16(15):1924-7. doi: 10.3748/wjg.v16.i15.1924.
3
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Cochrane Database Syst Rev. 2008 Jan 23(1):CD006893. doi: 10.1002/14651858.CD006893.
4
Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Dig Liver Dis. 2004 May;36(5):342-7. doi: 10.1016/j.dld.2003.12.014.
5
[Patients with cystic fibrosis become adults : Treatment hopes and disappointments].
Internist (Berl). 2019 Jan;60(1):98-108. doi: 10.1007/s00108-018-0536-9.
6
Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort.
Can J Gastroenterol. 2009 May;23(5):348-52. doi: 10.1155/2009/180840.
8
A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.
Korean J Gastroenterol. 2013 Sep;62(3):169-73. doi: 10.4166/kjg.2013.62.3.169.
9
[Successful primary infliximab treatment of orofacial Crohn's disease without gastrointestinal manifestation].
Korean J Gastroenterol. 2012 Jun 25;59(6):437-40. doi: 10.4166/kjg.2012.59.6.437.
10
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.
J Crohns Colitis. 2012 Mar;6(2):143-53. doi: 10.1016/j.crohns.2011.07.011. Epub 2011 Aug 31.

引用本文的文献

1
Intestinal luminal anion transporters and their interplay with gut microbiome and inflammation.
Am J Physiol Cell Physiol. 2025 May 1;328(5):C1455-C1472. doi: 10.1152/ajpcell.00026.2025. Epub 2025 Mar 6.
2
Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis.
Diagnostics (Basel). 2024 Jan 22;14(2):228. doi: 10.3390/diagnostics14020228.
3
Prevalence, Risk Factors, and Sequelae of Asymptomatic Clostridioides difficile Colonization in Children with Cystic Fibrosis.
J Cyst Fibros. 2023 Sep;22(5):884-887. doi: 10.1016/j.jcf.2022.12.014. Epub 2022 Dec 28.
4
Disrupted tight junctions in the small intestine of cystic fibrosis mice.
Cell Tissue Res. 2014 Jan;355(1):131-42. doi: 10.1007/s00441-013-1734-3. Epub 2013 Oct 30.
5
Metastatic bladder cancer presenting with persistent hematuria in young man with cystic fibrosis.
Case Rep Pulmonol. 2013;2013:831871. doi: 10.1155/2013/831871. Epub 2013 May 14.

本文引用的文献

2
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Cochrane Database Syst Rev. 2008 Jan 23(1):CD006893. doi: 10.1002/14651858.CD006893.
3
Safety of biologic therapy.
Inflamm Bowel Dis. 2007 Jun;13(6):769-96. doi: 10.1002/ibd.20027.
4
Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.
Antimicrob Agents Chemother. 2007 Mar;51(3):975-81. doi: 10.1128/AAC.01142-06. Epub 2007 Jan 8.
5
Abdominal manifestations of cystic fibrosis in older children and adults.
AJR Am J Roentgenol. 2006 Nov;187(5):1199-203. doi: 10.2214/AJR.05.0327.
6
Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease.
Inflamm Bowel Dis. 2006 Sep;12(9):831-6. doi: 10.1097/01.mib.0000232470.00703.67.
7
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
Gastroenterology. 2006 Apr;130(4):1054-61. doi: 10.1053/j.gastro.2006.02.014.
8
European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
Gut. 2006 Mar;55 Suppl 1(Suppl 1):i16-35. doi: 10.1136/gut.2005.081950b.
9
Predictors of immunomodulator use as early therapy in pediatric Crohn's disease.
J Clin Gastroenterol. 2006 Feb;40(2):145-8. doi: 10.1097/01.mcg.0000196192.49920.03.
10
Abdominal manifestations of cystic fibrosis in children.
Pediatr Radiol. 2006 Mar;36(3):233-40. doi: 10.1007/s00247-005-0049-2. Epub 2006 Jan 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验